97 related articles for article (PubMed ID: 21965139)
1. Hepatocellular carcinoma presenting with multiple bone and soft tissue metastases and atypical cytomorphological features--a rare case report.
Rastogi A; Bihari C; Jain D; Gupta NL; Sarin SK
Diagn Cytopathol; 2013 Jul; 41(7):640-3. PubMed ID: 21965139
[TBL] [Abstract][Full Text] [Related]
2. Initial presentation of hepatocellular carcinoma as soft tissue swelling of the forearm: A rare cytomorphological diagnosis.
Sinha RT; Dey A; Agarwal S
J Cancer Res Ther; 2015; 11(4):1032. PubMed ID: 26881625
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma with Cervical Spine and Pelvic Bone Metastases Presenting as Unknown Primary Neoplasm.
Hwang SW; Lee JE; Lee JM; Hong SH; Lee MA; Chun HG; Chun HJ; Lee SH; Jung ES
Korean J Gastroenterol; 2015 Jul; 66(1):50-4. PubMed ID: 26194130
[TBL] [Abstract][Full Text] [Related]
4. A typical presentation of a hepatocellular carcinoma in a middle-aged patient.
García Carretero R; Vazquez-Gomez O; Romero Brugera M; Rebollo-Aparicio N
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28830893
[No Abstract] [Full Text] [Related]
5. [A case of hepatocellular carcinoma treated by resection of metachronous rib metastasis after primary hepatectomy].
Takagi Y; Kametaka H; Makino H; Koyama T; Seike K; Hara J; Hasegawa A
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1834-6. PubMed ID: 23267902
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.
Gadaleta-Caldarola G; Divella R; Mazzocca A; Infusino S; Ferraro E; Filippelli G; Daniele A; Sabbà C; Abbate I; Brandi M
Future Oncol; 2015; 11(16):2263-6. PubMed ID: 26260805
[No Abstract] [Full Text] [Related]
7. Complete regression of multiple painful bone metastases from hepatocellular carcinoma after administration of strontium-89 chloride.
Suzawa N; Yamakado K; Takaki H; Nakatsuka A; Takeda K
Ann Nucl Med; 2010 Oct; 24(8):617-20. PubMed ID: 20490724
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma treated by sorafenib with complete radiological response according to mRECIST criteria: could we stop the treatment? About four cases.
Poullenot F; Bioulac-Sage P; Laumonier H; Saric J; Carteret T; Blanc JF
Acta Oncol; 2014 Mar; 53(3):420-3. PubMed ID: 23713857
[No Abstract] [Full Text] [Related]
9. The role of sorafenib in hepatocellular carcinoma.
Gholam P
Clin Adv Hematol Oncol; 2015 Apr; 13(4):232-4. PubMed ID: 26352581
[No Abstract] [Full Text] [Related]
10. [Complete response to treatment with low-dose FP therapy in a patient with stage IVB primary hepatocellular carcinoma with multiple lung and bone metastases].
Fukuda Y; Fujio N; Takatori H; Tsukazaki T; Terakura M; Mayumi K; Koyama I; Tsukazaki Y; Osugi H
Gan To Kagaku Ryoho; 2004 Jan; 31(1):107-11. PubMed ID: 14750333
[TBL] [Abstract][Full Text] [Related]
11. [Bone metastasis of hepatocarcinoma. Review of the literature, radiologic pictures and personal caseload].
Borghetti M; Benelli G; Bonardi R; Reduzzi L; Iori M
Radiol Med; 1991; 82(1-2):48-51. PubMed ID: 1654579
[TBL] [Abstract][Full Text] [Related]
12. Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib.
Dai X; Schlemmer HP; Schmidt B; Höh K; Xu K; Ganten TM; Ganten MK
Eur J Radiol; 2013 Feb; 82(2):327-34. PubMed ID: 23246016
[TBL] [Abstract][Full Text] [Related]
13. A rare primary liver tumor that responded to sorafenib.
Seino S; Tsuchiya A; Watanabe M
Gastroenterology; 2014 Dec; 147(6):1226-7. PubMed ID: 25450081
[No Abstract] [Full Text] [Related]
14. Treatment of intermediate-stage hepatocellular carcinoma.
Finn RS
Clin Adv Hematol Oncol; 2015 Aug; 13(8):501-3. PubMed ID: 26351811
[No Abstract] [Full Text] [Related]
15. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan.
Takeda H; Nishikawa H; Osaki Y; Tsuchiya K; Joko K; Ogawa C; Taniguchi H; Orito E; Uchida Y; Izumi N;
Liver Int; 2015 May; 35(5):1581-9. PubMed ID: 24836552
[TBL] [Abstract][Full Text] [Related]
16. Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma.
Suzuki E; Ooka Y; Chiba T; Kobayashi K; Kanogawa N; Motoyama T; Saito T; Ogasawara S; Tawada A; Yokosuka O
Clin J Gastroenterol; 2015 Feb; 8(1):41-6. PubMed ID: 25481841
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study.
Lee S; Kim BK; Kim SU; Park SY; Kim JK; Lee HW; Park JY; Kim DY; Ahn SH; Tak WY; Kweon YO; Lee JI; Lee KS; Kim HJ; Han KH
J Gastroenterol Hepatol; 2014; 29(7):1463-9. PubMed ID: 25273508
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma with skeletal metastasis.
Golimbu C; Firooznia H; Rafii M
Radiology; 1985 Mar; 154(3):617-8. PubMed ID: 2982174
[TBL] [Abstract][Full Text] [Related]
19. Extrahepatic spread of hepatocellular carcinoma.
Cabibbo G; Compilato D; Genco C; Campisi G
Panminerva Med; 2012 Dec; 54(4):313-22. PubMed ID: 23123584
[TBL] [Abstract][Full Text] [Related]
20. [A case of hepatocellular carcinoma with bone metastasis which responded to oral administration of UFT].
Inada M; Minami Y; Kawata S; Miyoshi S; Imai Y; Saito R; Noda S; Tamura S; Inui Y; Matsuda Y
Gan To Kagaku Ryoho; 1987 Feb; 14(2):531-5. PubMed ID: 3028279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
